Clinical Trials on CD20-Positive Lymphoid Malignancies
Total 895 results
-
AbbVieGenentech, Inc.Active, not recruitingNon-Hodgkin's Lymphoma | Hematological Malignancies | Chronic Lymphoid Leukemia | CD20-Positive Lymphoid MalignanciesUnited States, Australia
-
The First Affiliated Hospital of Soochow UniversityShanghai Unicar-Therapy Bio-medicine Technology Co.,LtdUnknownRefractory Non-Hodgkin Lymphoma | Relapsed Non Hodgkin Lymphoma | CAR - T CD19/CD20/CD22/CD30China
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedHematopoietic and Lymphoid Cell Neoplasm | Lymphoma | CD20 Positive | Lymphocytic NeoplasmUnited States
-
Mentrik Biotech, LLCUnknownPreviously Treated CD20+ B-cell MalignanciesUnited States
-
Eric Bernicker, MDMillennium Pharmaceuticals, Inc.; The Methodist Hospital Research InstituteWithdrawnCD30-positive Lymphoma | CD30-positive Solid TumorUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompletedCD30-Positive Diffuse Large B-Cell Lymphoma | CD30 Positive Primary Mediastinal Large B-cell Lymphoma | CD30-Positive Gray Zone LymphomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Mantle Cell Lymphoma | Mantle Cell Lymphoma | CCND1 Positive | CCND2 Positive | CCND3 Positive | CD20 Positive | Refractory Mantle Cell LymphomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)WithdrawnMantle Cell Lymphoma | CCND1 Positive | CD20-Positive Neoplastic Cells Present
-
Maria Sklodowska-Curie National Research Institute...KCRINot yet recruitingCD20-positive Acute Lymphoblastic LeukemiaPoland
-
Guangzhou Excelmab Inc.RecruitingSafety and Efficacy of EX103 in Subjects With Relapsed/Refractory CD20-Positive Non-Hodgkin LymphomaCD20-positive Non-Hodgkin LymphomaChina
-
Conjupro Biotherapeutics, Inc.SuspendedCD20 Positive Non Hodgkin LymphomaUnited States
-
Seoul National University HospitalGyeongsang National University Hospital; Hallym University Medical Center; Kyunghee...TerminatedCD20-positive Non-Hodgkin LymphomaKorea, Republic of
-
PersonGen BioTherapeutics (Suzhou) Co., Ltd.Peking University People's Hospital; The First Affiliated Hospital of Zhengzhou... and other collaboratorsRecruitingCD7-positive Relapsed/Refractory Lymphoid Hematologic MalignanciesChina
-
Poitiers University HospitalCompleted
-
Curon Biopharmaceutical (Australia) Co Pty LtdNovotech (Australia) Pty LimitedTerminatedRelapsed Lymphoid Malignancies | Refractory Lymphoid MalignanciesAustralia
-
Shanghai Henlius BiotechWithdrawnCD20-positive Follicular Lymphoma, With Low Tumour Burden
-
University of CologneUnknownCD30 Positive Cutaneous T Cell Lymphoma | CD30 Positive Transformed Mycosis FungoidesGermany
-
Zhejiang Teruisi Pharmaceutical Inc.RecruitingCD20-positive B-cell Non-Hodgkin LymphomaChina
-
Medical College of WisconsinMidwest Athletes Against Childhood CancerNot yet recruitingLymphoma | Leukemia | Hodgkin Disease | CD30-Positive Diffuse Large B-Cell Lymphoma | CD30+ Anaplastic Large Cell Lymphoma | CD30+ Pleomorphic Large T-Cell Cutaneous Lymphoma | CD30+ Immunoblastic Large T-Cell Cutaneous LymphomaUnited States
-
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.RecruitingStudy of IMM0306 in Patients With Relapsed or Refractory CD20-positive B-cell Non-Hodgkin's LymphomaCD20-positive B-cell Non-Hodgkin's LymphomaChina
-
Shanghai Pharmaceuticals Holding Co., LtdCompletedCD20 Positive B Cell Non-Hodgkin's LymphomaChina
-
Beijing Mabworks Biotech Co., Ltd.CompletedCD20-positive B Cell Non-Hodgkin LymphomaChina
-
Janssen Research & Development, LLCPharmacyclics LLC.CompletedCD20-positive B-cell Non-Hodgkin LymphomaUnited States, France
-
Sunshine Guojian Pharmaceutical (Shanghai) Co.,...Unknown
-
Lymphoma Study AssociationTerminatedCD20-Positive Large B-Cell LymphomaFrance
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Mantle Cell Lymphoma | CD20 Positive | Refractory Mantle Cell Lymphoma | Blastoid Variant Mantle Cell Lymphoma | CCND1 Protein Overexpression | CD5 Positive | FCER2 Negative | Pleomorphic Variant Mantle Cell Lymphoma | t(11;14)(q13;q32)United States
-
Novartis PharmaceuticalsRecruitingALK Positive MalignanciesGermany, France, Australia, Belgium, Italy, Korea, Republic of, Poland, China, United States, Taiwan, Brazil, Bulgaria, Hong Kong, Japan, Lebanon, Malaysia, Spain, Russian Federation, Colombia, Singapore, Czechia
-
Lymphoma Study AssociationAmgenCompletedUntreated CD20-positive Large B-cell LymphomaFrance
-
The Lymphoma Academic Research OrganisationHoffmann-La RocheTerminatedDiffuse Large B Cell Lymphoma CD20 PositiveFrance, Belgium
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)RecruitingMantle Cell Lymphoma | CD20 PositiveUnited States
-
Shanghai Jiao Tong University School of MedicineCompletedLymphoid MalignanciesChina
-
Human Genome Sciences Inc.TerminatedLymphoid MalignanciesUnited States, United Kingdom
-
Gilead SciencesTerminatedLymphoid MalignanciesNetherlands
-
National Cancer Institute (NCI)CompletedRefractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | CD20 PositiveUnited States
-
Fujian Medical UniversityRecruitingRelapsed or Refractory DLBCL Patients With Either CD19 or CD20 PositiveChina
-
Nantes University HospitalGilead Sciences; Institut Cancerologie de l'OuestWithdrawnLymphocyte B CD22 Positive Acute Lymphoblastic Leukemia
-
TakedaCompletedUntreated CD30-Positive Hodgkin's LymphomaJapan
-
Fondazione Italiana Linfomi ONLUSTerminatedCD20 Positive Diffuse Large B-cell Lymphoma | Elderly Unfit PatientsItaly
-
Regeneron PharmaceuticalsTerminatedAdvanced PD-L1 Positive MalignanciesUnited States
-
Cristina GasparettoAgilent Technologies, Inc.Active, not recruitingLymphoid Malignancies | Myeloid MalignanciesUnited States
-
University of WashingtonNational Cancer Institute (NCI)WithdrawnAnaplastic Large Cell Lymphoma, ALK-Positive | CD30-Positive Neoplastic Cells Present | Systemic Anaplastic Large Cell LymphomaUnited States
-
Shanghai Escugen Biotechnology Co., LtdEscugen (Australia) Biotechnology Pty LtdNot yet recruitingB-cell Lymphoid Malignancies
-
M.D. Anderson Cancer CenterReata Pharmaceuticals, Inc.CompletedSolid Tumors | Lymphoid MalignanciesUnited States
-
Shanghai Escugen Biotechnology Co., LtdRecruitingB-cell Lymphoid MalignanciesChina
-
Baptist Health South FloridaWithdrawnNon-Hodgkin Lymphoma | Hematologic Malignancy | B-Cell Lymphoid MalignanciesUnited States
-
National Cancer Institute (NCI)RecruitingLymphoma | Non-Hodgkin Lymphoma | NHL | Hematologic Malignancies | Lymphoid MalignanciesUnited States
-
OncoMed Pharmaceuticals, Inc.CompletedRelapsed or Refractory Lymphoid MalignanciesUnited States
-
Reata, a wholly owned subsidiary of BiogenCompletedAdvanced Solid Tumors | Lymphoid MalignanciesUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedFollicular Lymphoma | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Recurrent Diffuse Large B-Cell Lymphoma | CD20 Positive | T-Cell Non-Hodgkin LymphomaUnited States
-
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co...CompletedRefractory or Recurrent CD30+ Hematologic MalignanciesChina